Pulp regeneration compositions and methods of forming and using the same

US12016938B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12016938-B2
Application numberUS-202217969990-A
CountryUS
Kind codeB2
Filing dateOct 20, 2022
Priority dateDec 1, 2016
Publication dateJun 25, 2024
Grant dateJun 25, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A dental tissue regenerative composition. The composition includes a combination of (1) human dental pulp stem cells and (2) at least one of human umbilical vein endothelial cells or vascular endothelial growth factor. The combination is encapsulated in a light-activated gelatin methacrylate hydrogel.

First claim

Opening claim text (preview).

What is claimed is: 1. A three-dimensional biomimetic model comprising: a tissue regenerative composition comprising a material at least partly obtained from an extracted tooth, and a light-activated hydrogel encapsulating the material; a biomimetic enamel organ layer, and a biomimetic pulp organ. 2. The three-dimensional biomimetic model of claim 1 , wherein the tissue regenerative composition a photo-initiator. 3. The three-dimensional biometric model of claim 2 , wherein the photo-initiator is present at a concentration of about 0.05% to about 0.5% (w/v). 4. The three-dimensional biometric model of claim 2 , wherein the photo-initiator is selected from the group consisting of: 1-[4-(2-hydroxy ethoxy)-phenyl]-2-hydroxy-2-methyl-1-propane-1-one, azobisisobutyronitrile, benzoyl peroxide, di-tert-butyl peroxide, 2,2-dimethoxy-2-phenylacetophenone, Eosin Y, and any combination thereof. 5. The three-dimensional biometric model of claim 1 , wherein the hydrogel is a gelatin methacrylate hydrogel. 6. The three-dimensional biometric model of claim 5 , wherein the gelatin methacrylate hydrogel is present at a concentration of about 3% to about 5% (w/v). 7. The three-dimensional biometric model of claim 1 , wherein the material obtained from the extracted tooth includes dental pulp stem cells. 8. The three-dimensional biometric model of claim 7 , wherein the material further includes at least one of umbilical vein endothelial cells or vascular endothelial growth factor. 9. The three-dimensional biometric model of claim 7 , wherein the dental pulp stem cells have been isolated from dental pulp. 10. The three-dimensional biometric model of claim 9 , wherein the dental pulp is from a mature tooth. 11. A method of forming a three-dimensional biometric model, the method comprising: forming a biomimetic enamel organ layer from a first material at least partly obtained from an extracted tooth, the first material being encapsulated in a light-activated hydrogel; and forming a biomimetic pulp organ from a second material at least partly obtained from an extracted tooth, the second material being encapsulated in the light-activated hydrogel. 12. The method of claim 11 , wherein the hydrogel is a gelatin methacrylate hydrogel. 13. The method of claim 12 , wherein the gelatin methacrylate hydrogel is present at a concentration of about 3% to about 5% (w/v). 14. The method of claim 11 , wherein at least one of the first and second materials obtained from the extracted tooth includes dental pulp stem cells. 15. The method of claim 14 , wherein at least one of the first and second materials further comprises at least one of umbilical vein endothelial cells or vascular endothelial growth factor. 16. The method of claim 14 , wherein the dental pulp stem cells have been isolated from dental pulp. 17. The method of claim 16 , wherein the dental pulp is from a mature tooth. 18. The three-dimensional biomimetic model of claim 1 , wherein the biomimetic enamel organ layer includes epithelial cells. 19. The three-dimensional biomimetic model of claim 1 , wherein the biomimetic pulp organ includes mesenchymal cells. 20. The method of claim 11 , wherein the first material includes epithelial cells. 21. The method of claim 11 , wherein the second material includes mesenchymal cells.

Assignees

Inventors

Classifications

  • Apical treatment · CPC title

  • Implements for surgical treatment of the roots or nerves of the teeth; Nerve needles; Methods or instruments for medication of the roots · CPC title

  • Medicaments · CPC title

  • A61K6/62Primary

    Photochemical radical initiators · CPC title

  • for dental implants or prostheses · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12016938B2 cover?
A dental tissue regenerative composition. The composition includes a combination of (1) human dental pulp stem cells and (2) at least one of human umbilical vein endothelial cells or vascular endothelial growth factor. The combination is encapsulated in a light-activated gelatin methacrylate hydrogel.
Who is the assignee on this patent?
Tufts College, Brigham & Womens Hospital Inc
What technology area does this patent fall under?
Primary CPC classification A61K6/62. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).